Search Results - "Wolthers, B O"
-
1
Asparaginase-associated pancreatitis: a study on phenotype and genotype in the NOPHO ALL2008 protocol
Published in Leukemia (01-02-2017)“…Asparaginase (ASP)-associated pancreatitis (AAP) occurs during acute lymphoblastic leukemia treatment. Among 1285 children (1.0–17.9 years) diagnosed during…”
Get full text
Journal Article -
2
Intermittent Versus Continuous PEG-Asparaginase to Reduce Asparaginase-Associated Toxicities: A NOPHO ALL2008 Randomized Study
Published in Journal of clinical oncology (01-07-2019)“…Asparaginase is an essential drug in childhood acute lymphoblastic leukemia (ALL) therapy and is frequently given for months to obtain continuous asparagine…”
Get full text
Journal Article -
3
Acute liver failure in a four-year old girl during maintenance therapy of acute lymphoblastic leukemia
Published in Pediatric hematology and oncology (03-10-2021)Get full text
Journal Article -
4
Effects of germ line DHFR and FPGS variants on methotrexate metabolism and relapse of leukemia
Published in Blood (2020)“…Methotrexate (MTX) during maintenance therapy is essential for curing acute lymphoblastic leukemia (ALL), but dosing strategies aiming at adequate treatment…”
Get full text
Journal Article -
5
NT5C2 germline variants alter thiopurine metabolism and are associated with acquired NT5C2 relapse mutations in childhood acute lymphoblastic leukaemia
Published in Leukemia (01-12-2018)“…The antileukaemic drug 6-mercaptopurine is converted into thioguanine nucleotides (TGN) and incorporated into DNA (DNA-TG), the active end metabolite. In a…”
Get full text
Journal Article -
6
Relapse risk following truncation of pegylated asparaginase in childhood acute lymphoblastic leukemia
Published in Blood (29-04-2021)“…Truncation of asparaginase treatment due to asparaginase-related toxicities or silent inactivation (SI) is common and may increase relapse risk in acute…”
Get full text
Journal Article -
7
Genetic predisposition to PEG‐asparaginase hypersensitivity in children treated according to NOPHO ALL2008
Published in British journal of haematology (01-02-2019)“…Summary Asparaginase is essential in childhood acute lymphoblastic leukaemia (ALL) treatment, however hypersensitivity reactions to pegylated asparaginase…”
Get full text
Journal Article -
8
The Association between Asparaginase Enzyme Activity Levels and Toxicities in Childhood Acute Lymphoblastic Leukaemia in the NOPHO ALL2008 Protocol
Published in BLOOD (05-11-2020)“…▪ Introduction: Asparaginase is a key component in the treatment of childhood acute lymphoblastic leukemia (ALL), but the treatment is jeopardized by 20% or…”
Get full text
Journal Article Conference Proceeding -
9
Insulin‐dependent diabetes: A chronic complication to acute pancreatitis in childhood acute lymphoblastic leukemia
Published in Pediatric blood & cancer (01-01-2019)“…Pancreatitis is a frequent toxicity to acute lymphoblastic leukemia (ALL) treatment, significantly associated with asparaginase use, and may be followed by…”
Get full text
Journal Article -
10
Intermittent Vs Continuous Asparaginase to Reduce Asparaginase-Associated Toxicities: A NOPHO ALL2008 Randomized Study
Published in Blood (08-12-2017)“…▪ Introduction: Asparaginase is a cornerstone in the treatment of acute lymphoblastic leukemia (ALL), but it also causes a range of toxicities of which several…”
Get full text
Journal Article Conference Proceeding -
11
Genetic Variants in the HLA-genes Are Associated with PEG-asparaginase Allergy - a Genome Wide Association Study on the NOPHO ALL2008 Protocol
Published in Blood (08-12-2017)“…Introduction: Asparaginase is a cornerstone in treatment of childhood acute lymphoblastic leukemia (ALL). However, balancing positive anti-leukemic effect…”
Get full text
Journal Article Conference Proceeding -
12
Asparaginase-Associated Pancreatitis in ALL: Results from the NOPHO ALL2008 Treatment of Patients 1-45 Years
Published in BLOOD (13-11-2019)“…Premature discontinuation of asparaginase reduces cure rate in contemporary acute lymphoblastic leukemia (ALL) treatment. One of the commonest causes of…”
Get full text
Journal Article Conference Proceeding -
13
Asparaginase enzyme activity levels and toxicity in childhood acute lymphoblastic leukemia: a NOPHO ALL2008 study
Published in Blood advances (11-01-2022)“…Asparaginase treatment is a mainstay in contemporary treatment of acute lymphoblastic leukemia (ALL), but substantial asparaginase-related toxicity may lead to…”
Get full text
Journal Article -
14
Pharmacogenetics of the Central Nervous System—Toxicity and Relapse Affecting the CNS in Pediatric Acute Lymphoblastic Leukemia
Published in Cancers (12-05-2021)“…Despite improving cure rates in childhood acute lymphoblastic leukemia (ALL), therapeutic side effects and relapse are ongoing challenges. These can also…”
Get full text
Journal Article -
15